Uyen Ngoc Mui, MD
Dermatology · Katy, TXNPI 1033572136
Payments from drug & device makers
Across 424 payments — averaging $775.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$232K
- Eli Lilly$85K
- AbbVie$3K
- Sanofi$2K
- Amgen$1K
- Regeneron Healthcare Solutions, Inc.$852
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 6 | $231,916 |
| Eli Lilly | 8 | $84,745 |
| AbbVie | 129 | $2,500 |
| Sanofi | 17 | $2,218 |
| Amgen | 28 | $1,058 |
| Regeneron Healthcare Solutions, Inc. | 31 | $852 |
| Johnson & Johnson | 36 | $726 |
| Sun Pharmaceutical Industries Inc. | 24 | $624 |
| Lilly USA, LLC | 31 | $601 |
| Arcutis Biotherapeutics, Inc. | 15 | $393 |
| Novartis | 15 | $349 |
| Galderma Laboratories, L.p. | 5 | $279 |
| E.r. Squibb & Sons, L.L.C. | 3 | $263 |
| Incyte Corporation | 14 | $261 |
| Pfizer | 14 | $245 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $228 |
| LEO Pharma Inc. | 2 | $190 |
| Organon | 8 | $185 |
| Dermavant Sciences, Inc. | 12 | $178 |
| Journey Medical Corporation | 5 | $151 |
| Kerecis Limited | 1 | $133 |
| Bristol Myers Squibb | 1 | $124 |
| Boehringer Ingelheim | 1 | $120 |
| Janssen Scientific Affairs, LLC | 1 | $119 |
| Verrica Pharmaceuticals Inc. | 5 | $97 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Genentech USA, Inc. | 3 | $28 |
| UCB, Inc. | 1 | $23 |
| LNHC, Inc | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$328,689 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Katy
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.